Military Introduces New Brain Injury Diagnostics for Soldiers
軍方引進士兵腦部損傷新診斷技術
更新於: 2026年8月4日 上午01:30
The U.S. military is transforming battlefield medicine with the introduction of a groundbreaking handheld diagnostic tool designed to detect Traumatic Brain Injury (TBI) in soldiers.
美國軍方正在透過引入一款開創性的手持式診斷工具，革新戰場醫療，該裝置旨在檢測士兵的創傷性腦損傷（TBI）。
The new device, known as the i-STAT Alinity, shifts the standard to objective, biomarker-based analysis.
這款名為i-STAT Alinity的新裝置，將標準轉向客觀的生物標記分析。
By analyzing a small blood sample for specific proteins—ubiquitin carboxyl-terminal hydrolase L1 (UCH-L1) and glial fibrillary acidic protein (GFAP)—the device can identify signs of brain injury in just 15 minutes.
透過分析少量血液樣本中的特定蛋白質——泛素羧基末端水解酶L1（UCH-L1）和神經膠細胞纖維酸性蛋白（GFAP），該裝置僅需15分鐘即可識別腦部損傷跡象。
With a 99% accuracy rate in ruling out brain bleeds, this technology is more sensitive than standard CT scans.
在排除腦部出血方面，其準確率達99%，此項技術比標準的電腦斷層掃描（CT）更加靈敏。
Currently being deployed to remote forward units, this innovation allows medical providers to make faster, more informed decisions about whether a soldier needs evacuation or can safely remain on duty.
此項創新正被部署至偏遠的前線部隊，讓醫療提供者能更快、更準確地決定士兵是否需要撤離，或是能否安全留守崗位。
By reducing unnecessary medical flights and providing precise data, this advancement marks the most significant leap in military TBI care in decades, supporting the Department of Defense’s broader commitment to brain health for all service members.
透過減少不必要的醫療專機運送並提供精確的數據，這項進步標誌著數十年來軍事TBI護理領域最重要的飛躍，並支援國防部對全體服役人員腦部健康的廣泛承諾。
